With a revenue increase of 166.66% in the second quarter 2026, year on year to cumulative value of $38 million, Cue Biopharma Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,298,414, this marks a new company high.
Within the Healthcare sector Employees of 74 other companies have achieved higher revenue per employee. While Cue Biopharma Inc 's total ranking has deteriorated compared to the previous quarter from 707 to 773. Cue Biopharma Inc has 29 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CUE Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	166.66 %	1250.59 %	1292.26 %	-35.58 %	11.14 %
Sales per Employee (TTM) $	1,298,414	1,128,655	947,103	244,828	285,759
CUE's Total Ranking	# 773	# 707	# 2122	# 2210	# 2661
Seq. Revenue Change	38.53 %	-74.09 %	921.03 %	-27.25 %	601.66 %

CUE Company Profile >> Back to CUE Efficiency Comparisons >> Compare CUE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 51
Healthcare Sector	# 75
Overall Market	# 773

Revenue per Employee Statistics
High	Average	Low
$ 1,298,414	$ 339,296	$ 14,904
(Jun 30 2026)		(Mar 31 2023)

Financial Statements
Cue Biopharma Inc 's Revenue MRQ	$ 8 Millions	Visit CUE's Income Statement
Cue Biopharma Inc 's Revenues TTM	$ 38 Millions	Visit CUE's aggregate revenue growth
What are CUE's Sales?		Visit CUE's Sales by Segment

Other Ratios
Cue Biopharma Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CUE's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CUE's Competitors
Revenue per Employee for CUE's Suppliers
Revenue per Employee for CUE's Customers

You may also want to know
CUE's Sales Growth Rates	CUE's Pe Price to earnings ratio	CUE's Receivables Turnover Ratio	CUE's Stock Quote
CUE's Net Income Growth Rates	CUE's Ps Price to Sales ratio	CUE's Sales per Employee	CUE's Asset Turnover Ratio
CUE's Net Margin	CUE's Pb Price to Book ratio	CUE's Financial Strength Ratios	CUE's Dividend Payout Ratio

Date modified: 2026-09-08T17:18:51+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Biocryst Pharmaceuticals Inc	2,162,328.74	$ 940.613 Million	435
Elite Pharmaceuticals Inc	2,155,839.86	$ 140.130 Million	65
Zevra Therapeutics Inc	2,112,377.05	$ 128.855 Million	61
Liquidia Corporation	2,087,532.41	$ 450.907 Million	216
Tg Therapeutics Inc	2,003,849.62	$ 799.536 Million	399
Prestige Consumer Healthcare Inc	1,938,521.05	$ 1,104.957 Million	570
Privia Health Group Inc	1,923,384.18	$ 2,358.069 Million	1,226
Gilead Sciences Inc	1,791,588.24	$ 30,457.000 Million	17,000
Collegium Pharmaceutical Inc	1,777,172.58	$ 751.744 Million	423
Fennec Pharmaceuticals Inc	1,692,028.57	$ 59.221 Million	35
Neurocrine Biosciences Inc	1,686,950.00	$ 3,373.900 Million	2,000
Mirum Pharmaceuticals Inc	1,661,470.43	$ 618.067 Million	372
Tarsus Pharmaceuticals Inc	1,638,732.43	$ 606.331 Million	370
Agenus Inc	1,638,185.19	$ 132.693 Million	81
Xenetic Biosciences Inc	1,630,388.50	$ 3.261 Million	2
Ideaya Biosciences Inc	1,614,668.97	$ 234.127 Million	145
Rigel Pharmaceuticals Inc	1,590,718.39	$ 276.785 Million	174
Progyny Inc	1,531,890.19	$ 1,311.298 Million	856
Acadia Pharmaceuticals Inc	1,426,870.93	$ 1,138.643 Million	798
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Puma Biotechnology Inc	1,291,865.92	$ 231.244 Million	179
Arvinas Inc	1,287,398.37	$ 316.700 Million	246
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Theravance Biopharma inc	1,159,011.11	$ 104.311 Million	90
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730
Akebia Therapeutics Inc	1,129,175.26	$ 219.060 Million	194

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.